Sporidesmin toxicity in rabbits: biochemical and morphological changes.
The earliest lesion in rabbits dosed orally with 2 mg of sporidesmin per kg of body weight was necrosis of occasional hepatocytes 1 day after dosing. The most consistent lesion was a severe necrotizing cholangitis of medium and large-sized intrahepatic and extrahepatic bile ducts, first seen 2 days after dosing. Similar lesions were also present in the gall bladder of some rabbits. Expansion of portal triads with fibrous tissue and proliferating bile ductules progressed to pseudo-lobulation by 21 days. Other hepatic changes observed irregularly included large infarcts at the periphery of some lobes, and multiple small foci of coagulation necrosis in midzonal and periportal regions. Vascular necrosis and thrombosis, invariably adjacent to necrotic bile ducts, was presumably responsible for the hepatic necrosis. Serum cholesterol and total bilirubin concentrations and GGT activity reached peaks 15 days after dosing and were useful indicators of the severity of biliary lesions. Serum ID activity was the most useful indicator of hepatic necrosis following oral dosing with sporidesmin. The similarity between hepatobiliary lesions observed in sheep and rabbits with experimental sporidesmin toxicity suggests that the rabbit would be a useful model for studying methods of treatment and prevention of "facial eczema" in ruminants.
D000818:Animals; D001659:Biliary Tract / Q000187:drug effects; D001663:Bilirubin / Q000097:blood; D002761:Cholangitis / Q000139:chemically induced; D002784:Cholesterol / Q000097:blood; D007211:Indoles / Q000633:toxicity*; D007238:Infarction; D008099:Liver / Q000098:blood supply / Q000187:drug effects; D009336:Necrosis; D011817:Rabbits; D013173:Sporidesmins / Q000633:toxicity*; D013997:Time Factors; D005723:gamma-Glutamyltransferase / Q000097:blood
D007211:Indoles; D013173:Sporidesmins; D002784:Cholesterol; D005723:gamma-Glutamyltransferase; D001663:Bilirubin